You just read:

Palatin Technologies Receives Notice of Allowance on Bremelanotide Methods of Use Patent for Treatment of Hypoactive Sexual Desire Disorder in Premenopausal Women

News provided by

Palatin Technologies, Inc.

Mar 20, 2017, 07:30 ET